Ignite Creation Date:
2025-12-25 @ 1:16 AM
Ignite Modification Date:
2026-02-06 @ 7:21 AM
Study NCT ID:
NCT04617093
Status:
COMPLETED
Last Update Posted:
2025-10-01
First Post:
2020-10-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-Market Study of Low-flow ECCO2R Using PrismaLung+
Sponsor:
Vantive Health LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Mild to Moderate Acute Respiratory Distress Syndrome | View |
Keywords: